Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Felodipine and hydrochlorothiazide pharmacokinetics and pharmacodynamics study in healthy volunteers
ChiCTR-OPC-15006271Phase 4Not yet recruiting
- Sponsor
- Pharmacogenetics Research Institute, Xiangya Hospital, Central South University
- Start
- Apr 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of felodipine and hydrochlorothiazide in hypertension (HTN), sponsored by Pharmacogenetics Research Institute, Xiangya Hospital, Central South University. Primary endpoint: Blood drug concentration. Planned start Apr 2015; status: not yet recruiting.
02
Drugs
felodipinehydrochlorothiazide
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on ChiCTR-OPC-15006271.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-OPC-15006271.